8 Stocks Jim Cramer Discussed & Mentioned An Important Quantum Computing Development

Page 7 of 7

1. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders In Q2 2025: 119

As he discussed Amgen, it was unsurprising that weight loss drug giant Eli Lilly and Company (NYSE:LLY) also caught Cramer’s attention. Throughout 2025, the CNBC TV host has remained an ardent believer in the stock. Some of the reasons he’s cited for being optimistic about Eli Lilly and Company (NYSE:LLY) include the firm’s manufacturing investments in the US, a weight loss pill that it’s developing, and its drug portfolio excluding weight loss drugs. In this appearance, Cramer commented on Eli Lilly and Company (NYSE:LLY)’s CEO, David Ricks, and the weight loss pill:

“Look the pill is going to be, Dr. Bourla was here and he was talking about something that in three years could challenge them. All that did was make the stock go up another hundred points. Three years, Dave Ricks, I don’t think people realize, by the way, Lilly, incredibly charitable when it comes to any ailments, but, Dave Ricks is a great spokesperson for the industry.”

While we acknowledge the potential of LLY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LLY and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 7 of 7